Latest Sirolimus Stories
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer's disease.
JAMAICA PLAIN, Mass., Feb. 4 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD).
Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease.
Tuberous sclerosis, commonly associated with autism, is linked to defects in axon guidance.
LA JOLLA, Calif., Jan. 5 /PRNewswire/ -- Intellikine, Inc.
After suffering heart attacks, patients often receive stents designed to hold their arteries open.
A drug that has become a mainstay of multiple myeloma treatment may outperform alternative therapies in re-establishing the immune system of patients who have received stem cell transplants from unrelated, partially matched donors.
FORT LAUDERDALE, Fla., Dec.
JAMAICA PLAIN, Mass., Nov. 16 /PRNewswire/ -- Paloma Pharmaceuticals, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).